Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) FCF Margin (2016 - 2025)

Historic FCF Margin for iBio (IBIO) over the last 17 years, with Q3 2025 value amounting to 5732.0%.

  • iBio's FCF Margin changed N/A to 5732.0% in Q3 2025 from the same period last year, while for Dec 2025 it was 6391.0%, marking a year-over-year decrease of 20270000.0%. This contributed to the annual value of 3830.0% for FY2025, which is 45300000.0% up from last year.
  • Per iBio's latest filing, its FCF Margin stood at 5732.0% for Q3 2025.
  • In the past 5 years, iBio's FCF Margin ranged from a high of 366.0% in Q1 2022 and a low of 12464.29% during Q3 2021
  • In the last 5 years, iBio's FCF Margin had a median value of 2302.5% in 2025 and averaged 4386.88%.
  • Examining YoY changes over the last 5 years, iBio's FCF Margin showed a top increase of 29251700bps in 2021 and a maximum decrease of -106377000bps in 2021.
  • Over the past 5 years, iBio's FCF Margin (Quarter) stood at 12464.29% in 2021, then soared by 97bps to 366.0% in 2022, then tumbled by -2818bps to 10680.0% in 2023, then surged by 82bps to 1943.0% in 2024, then tumbled by -195bps to 5732.0% in 2025.
  • Its FCF Margin was 5732.0% in Q3 2025, compared to 2302.5% in Q2 2025 and 1943.0% in Q4 2024.